From the underpinning research that can lead to new treatments, to developing drugs for patients, our researchers are working hard to find new ways to tackle cancer. Below are some examples of what our researchers are doing right now.
Professor Ian Hitchcock in York is focusing on faulty versions of a gene called JAK2 that's found in a group of blood cancers called myloproliferative neoplasms. He's already found that the mutated version of JAK2 only works if it can act through a specific molecule called MPL. And as there are already drugs that can affect MPL, he believes that by targeting the molecule with drugs he can indirectly stop the effects of faulty JAK2, stopping these blood cancers in their tracks.
Find out more about myeloproliferative neoplasms
Professor Henning Walczak in London is working to target a cell death pathway triggered by a molecule in cells called TRAIL. He's investigating if targeting molecules in the pathway could work as a treatment for certain cancers where the TRAIL pathway is faulty. This could lead to the development of new treatments for people with these cancers.
Read more about TRAIL on our blog
Thanks to research, we’ve helped develop cancer drugs that are being used to treat cancer.
Meet people like Alfred who have experienced first-hand how our research is making a difference. The life-saving research we do wouldn’t be possible without your support.
Want to find more information about our research or cancer drugs?
